A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants

​ Conditions: Healthy Participants

Interventions: Drug: Povorcitinib; Drug: Ruxolitinib

Sponsors: Incyte Corporation

Recruiting Conditions: Healthy Participants
Interventions: Drug: Povorcitinib; Drug: Ruxolitinib
Sponsors: Incyte Corporation
Recruiting